---
created: 2025-04-13
updated: 2025-04-13T10:53
id: cW}WzkRoAC
specialty: cardio
specialty_id: 305
tags:
  - source/ak-original-decks::step-2::cheesy-dorian-(m3)
  - "source/ak-step2-v11::!shelf:": 
  - theme/cards-anking-skipped
  - source/ak-step2-v11::!shelf::im::no-dupes
  - source/ak-step2-v11::!shelf::im::no-dupes::only-step2
  - "source/ak-step2-v11:": 
  - theme/amboss::im
  - "source/ak-step2-v11:": 
  - theme/b&b::01-cardiology::heart-failure::hf-1-and-2
  - "source/ak-step2-v11:": 
  - theme/b&b::07-pulmonary::03-other-topics::01-pulmonary-hypertension
  - "source/ak-step2-v11:": 
  - theme/nbme
  - "source/ak-step2-v11:": 
  - theme/ome::01-cardiology::02-heart-failure
  - "source/ak-step2-v11:": 
  - source/ome-banner::clinical::01-cardiology::02-heart-failure
  - "source/ak-step2-v11:": 
  - theme/resources-by-rotation::im::ome::cardio::hf
  - "source/ak-step2-v11:": 
  - theme/resources-by-rotation::im::uw::cardio::cardio-dorian
  - "source/ak-step2-v11:": 
  - theme/resources-by-rotation::im::uw::cardio::cardio-zanki
  - "source/ak-step2-v11:": 
  - theme/subjects::cardiology::03-heart-failure::treatment
  - "source/ak-step2-v11:": 
  - theme/subjects::pulmonology::05-lungs::pulmonary-hypertension
  - "source/ak-step2-v11:": 
  - theme/uworld::10000-99999::11000-11999::11252
  - source/ak-step2-v11::original-decks::dorian::im::uw::cardio
  - source/ak-step2-v11::original-decks::zanki-step-2::im::cardio"
type: flashcard
---

# Question
What is the initial management for a patient with pulmonary hypertension that presents with JVD, peripheral edema, bibasilar crackles, and an ejection fraction of 30%?    **Loop diuretics and ACE inhibitors (or ARBs)**

---

# Answer
the pulmonary hypertension is due to LV systolic dysfunction and thus treatment involves addressing the underlying cause; diuretics will help with fluid overload and ACE-inhibitors will prevent further cardiac remodeling; Î²-blockers and occasionally aldosterone antagonists may be used for long-term management as well (note: endothelin-1 receptor antagonists and PDE-5 inhibitors are used for idiopathic pulmonary hypertension)